Medical Treatment in Ectopic Tubal Pregnancy

Status Completed

Clinical Trial Summary

Ectopic pregnancy (EP) is estimated to be responsible for approximately 20% of all pregnancy-related mortality and 46% early pregnancy mortality.1 Hemodynamically stable women with EP are frequently managed with methotrexate (MTX) while multiple protocols like fixed multiple doses, single-dose as well as two-dose regimens have been in practice for treating EP, but no consensus exists regarding the optimum dosage regimen.

Clinical Trial Description

Literature reports multiple dosage regimens of MTX to be associated with increased rates of side effects. Single dose protocol has good compliance and fewer side effects but is linked with lower success rates in comparison to multiple dose protocols. A new treatment protocol involving "two-doses" of MTX for medical management of EP was introduced in 2007 but most of the research conducted so far has been retrospective in nature and limitations in study designs. No such study in recent years has been done in Pakistan to compare the success and safety of single-dose and two-dose MTX protocols so this study was planned to compare the success rates and safety of two-doses of MTX versus single dose of MTX in tubal EP. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05208034
Study type	Interventional
Source	Nishtar Medical University
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2020
Completion date	July 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02995356` - Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy
Completed	`NCT01876004` - Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy	Phase 4
Not yet recruiting	`NCT05039853` - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task	N/A
Completed	`NCT00194207` - Risk Factors of Ectopic Pregnancy	N/A
Completed	`NCT00827970` - Randomized Population-Based Study on Chlamydia Trachomatis Screening	N/A
Recruiting	`NCT05374720` - Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy	N/A
Completed	`NCT03894735` - Vitamin D in Ectopic Pregnancies
Recruiting	`NCT01860690` - BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success	Phase 4
Recruiting	`NCT04176549` - Assessment of Biomarkers in Ectopic Pregnancy
Not yet recruiting	`NCT05890066` - Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy	N/A
Completed	`NCT01855568` - Methotrexate Treatment for Ectopic Pregnancy	Phase 3
Not yet recruiting	`NCT04308343` - The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy	N/A
Recruiting	`NCT06354439` - Use of Letrozole for Ectopic Pregnancy	Phase 4
Not yet recruiting	`NCT06300333` - Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
Completed	`NCT00194272` - Two-Dose Methotrexate for Ectopic Pregnancy	Phase 3
Enrolling by invitation	`NCT03579550` - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus	N/A
Completed	`NCT05446012` - Relationship Between Ectopic Pregnancy and Thyroid Disorders
Completed	`NCT00194168` - Ectopic Pregnancy Biomarkers	N/A
Completed	`NCT02152696` - Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location	Phase 3
Not yet recruiting	`NCT04975984` - Expectant Management of Ectopic Pregnancy